Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0001415889-25-002980 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-04 | 2025-01-31 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | — | +1,772 | 5,296 | +50% | — |
| D | 2025-02-04 | 2025-02-03 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | S - Sale+OE | $48.22 | -1,064 | 4,232 | -20% | -$51.3K |
| D | 2025-02-04 | 2025-01-31 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | $0.00 | -1,772 | 1,771 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | M | A | 1,772 | — | 5,296 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). |
| 2 | Common | Common Stock | 2025-02-03 | S | D | 1,064 | $48.22 | 4,232 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-01-31 | M | D | 1,772 | $0.00 | 1,771 | D | — · — to — | 1,772 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F3) The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. |